Liminatus Pharma Inc

Chart & performance

D1W1MN

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

Key people

Chris Kim

Chief Executive Officer, Director · since 2025

Scott Dam

Chief Financial Officer · since 2025

Lisha Parmar

Chief Financial Officer · since 2022

Beom Choi

Chief Technology Officer · since 2025

Byong Yoo

Chief Science Officer · since 2025

Omkar Halady

Vice President · since 2022

Sang-jin Lee

Head - Research & Development · since 2025

Richard Baek

Director · since 2025

Philip Lemons

Director · since 2025

Rohit Nanani

Director

Ji Yeon Baek

Independent Director · since 2025

Shashibhushan Borade

Independent Director · since 2023

Nicholas Fernandez

Independent Director · since 2023

Eun Sook Lee

Independent Director · since 2025

URL

http://liminatuspharma.com/

IPO date

May 18, 2021

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title in thousands, except ratios and share amounts	FY	FY	FY	FY	FY
Title in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT